A non deal roadshow is the most reliable means for a company to build a strong investor base. LifeSci Advisors markets its clients to the top life sciences-focused institutional investors across the U.S., Europe, and Israel. The investor outreach process commences with an individualized peer-comparable shareholder analysis followed by the creation of a target list of investors and a strategic marketing program incorporating the company’s expected corporate news flow and milestones.
In addition to deep relationships with the buy-side, LifeSci Advisors has strong connections with sell-side analysts, investment bankers, specialty salesman and capital markets professionals. The firm leverages these relationships on behalf of its clients to attract additional sell-side coverage, to encourage investor conference invites, and to expand investment banking relationships. Moreover, LifeSci Advisors has an extensive network of retail brokers across the U.S. interested in healthcare investment opportunities.
Asia Pacific is a global hub for life sciences and medical technology R&D, investment, and partnering. Within the region, companies and investors retain a robust appetite for innovative and cutting-edge healthcare technology.
LifeSci Advisors hosts Non-Deal Roadshows in multiple markets across Asia Pacific (China, Japan, Singapore, Taiwan, South Korea, etc.) focusing on investor and partner introductions for clients. Our team cultivates an extensive Asia Pacific network of institutional investors, venture capital funds with international investment capabilities, and local companies looking to globalize through licensing deals and joint ventures.